PT-141 serves as a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound acts by stimulating specific receptors within the body, causing to augmented sexual function. Research studies have indicated that PT-141 could significantly address a spectrum of sexual dysfunctions in bo